DAVIDE CAMPARI-MILANO NV (CPR.MI) Fundamental Analysis & Valuation
BIT:CPR • NL0015435975
Current stock price
6.11 EUR
+0 (+0.07%)
Last:
This CPR.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CPR.MI Profitability Analysis
1.1 Basic Checks
- In the past year CPR was profitable.
- CPR had a positive operating cash flow in the past year.
- In the past 5 years CPR has always been profitable.
- Each year in the past 5 years CPR had a positive operating cash flow.
1.2 Ratios
- CPR's Return On Assets of 4.27% is fine compared to the rest of the industry. CPR outperforms 66.67% of its industry peers.
- The Return On Equity of CPR (8.97%) is comparable to the rest of the industry.
- With a decent Return On Invested Capital value of 6.57%, CPR is doing good in the industry, outperforming 63.33% of the companies in the same industry.
- CPR had an Average Return On Invested Capital over the past 3 years of 6.98%. This is in line with the industry average of 7.69%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.27% | ||
| ROE | 8.97% | ||
| ROIC | 6.57% |
ROA(3y)3.87%
ROA(5y)4.55%
ROE(3y)8.5%
ROE(5y)9.99%
ROIC(3y)6.98%
ROIC(5y)7.33%
1.3 Margins
- CPR has a better Profit Margin (11.35%) than 66.67% of its industry peers.
- CPR's Profit Margin has been stable in the last couple of years.
- CPR has a Operating Margin of 19.74%. This is in the better half of the industry: CPR outperforms 66.67% of its industry peers.
- CPR's Operating Margin has improved in the last couple of years.
- CPR has a better Gross Margin (60.31%) than 83.33% of its industry peers.
- In the last couple of years the Gross Margin of CPR has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 19.74% | ||
| PM (TTM) | 11.35% | ||
| GM | 60.31% |
OM growth 3Y-1.78%
OM growth 5Y2.87%
PM growth 3Y-2.76%
PM growth 5Y1.37%
GM growth 3Y0.8%
GM growth 5Y0.82%
2. CPR.MI Health Analysis
2.1 Basic Checks
- CPR has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- The number of shares outstanding for CPR has been reduced compared to 1 year ago.
- The number of shares outstanding for CPR has been increased compared to 5 years ago.
- CPR has a better debt/assets ratio than last year.
2.2 Solvency
- An Altman-Z score of 2.63 indicates that CPR is not a great score, but indicates only limited risk for bankruptcy at the moment.
- With a decent Altman-Z score value of 2.63, CPR is doing good in the industry, outperforming 76.67% of the companies in the same industry.
- CPR has a debt to FCF ratio of 6.60. This is a slightly negative value and a sign of low solvency as CPR would need 6.60 years to pay back of all of its debts.
- The Debt to FCF ratio of CPR (6.60) is better than 66.67% of its industry peers.
- A Debt/Equity ratio of 0.59 indicates that CPR is somewhat dependend on debt financing.
- CPR has a Debt to Equity ratio of 0.59. This is in the better half of the industry: CPR outperforms 70.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 6.6 | ||
| Altman-Z | 2.63 |
ROIC/WACC1
WACC6.57%
2.3 Liquidity
- CPR has a Current Ratio of 2.22. This indicates that CPR is financially healthy and has no problem in meeting its short term obligations.
- CPR's Current ratio of 2.22 is fine compared to the rest of the industry. CPR outperforms 80.00% of its industry peers.
- CPR has a Quick Ratio of 2.22. This is a bad value and indicates that CPR is not financially healthy enough and could expect problems in meeting its short term obligations.
- CPR has a Quick ratio of 0.96. This is in the better half of the industry: CPR outperforms 76.67% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.22 | ||
| Quick Ratio | 0.96 |
3. CPR.MI Growth Analysis
3.1 Past
- CPR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 66.22%, which is quite impressive.
- The Earnings Per Share has been growing by 12.04% on average over the past years. This is quite good.
- Looking at the last year, CPR shows a decrease in Revenue. The Revenue has decreased by -0.60% in the last year.
- The Revenue has been growing by 11.48% on average over the past years. This is quite good.
EPS 1Y (TTM)66.22%
EPS 3Y-0.59%
EPS 5Y12.04%
EPS Q2Q%1418.89%
Revenue 1Y (TTM)-0.6%
Revenue growth 3Y4.19%
Revenue growth 5Y11.48%
Sales Q2Q%-2.8%
3.2 Future
- The Earnings Per Share is expected to grow by 18.72% on average over the next years. This is quite good.
- The Revenue is expected to grow by 3.29% on average over the next years.
EPS Next Y7.18%
EPS Next 2Y9.68%
EPS Next 3Y13.95%
EPS Next 5Y18.72%
Revenue Next Year1.23%
Revenue Next 2Y3.1%
Revenue Next 3Y4.86%
Revenue Next 5Y3.29%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. CPR.MI Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 21.07 indicates a rather expensive valuation of CPR.
- Compared to the rest of the industry, the Price/Earnings ratio of CPR indicates a slightly more expensive valuation: CPR is more expensive than 60.00% of the companies listed in the same industry.
- When comparing the Price/Earnings ratio of CPR to the average of the S&P500 Index (25.61), we can say CPR is valued inline with the index average.
- With a Price/Forward Earnings ratio of 18.85, CPR is valued on the expensive side.
- CPR's Price/Forward Earnings is on the same level as the industry average.
- The average S&P500 Price/Forward Earnings ratio is at 22.79. CPR is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.07 | ||
| Fwd PE | 18.85 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CPR is on the same level as its industry peers.
- The rest of the industry has a similar Price/Free Cash Flow ratio as CPR.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.37 | ||
| EV/EBITDA | 12.46 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- CPR has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as CPR's earnings are expected to grow with 13.95% in the coming years.
PEG (NY)2.93
PEG (5Y)1.75
EPS Next 2Y9.68%
EPS Next 3Y13.95%
5. CPR.MI Dividend Analysis
5.1 Amount
- CPR has a Yearly Dividend Yield of 1.67%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 2.68, CPR is paying slightly less dividend.
- Compared to an average S&P500 Dividend Yield of 1.89, CPR has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.67% |
5.2 History
- The dividend of CPR decreases each year by -0.23%.
Dividend Growth(5Y)-0.23%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
- CPR pays out 22.52% of its income as dividend. This is a sustainable payout ratio.
DP22.52%
EPS Next 2Y9.68%
EPS Next 3Y13.95%
CPR.MI Fundamentals: All Metrics, Ratios and Statistics
BIT:CPR (3/26/2026, 9:19:09 AM)
6.11
+0 (+0.07%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)03-04 2026-03-04/amc
Earnings (Next)05-06 2026-05-06
Inst Owners21.32%
Inst Owner ChangeN/A
Ins Owners50.85%
Ins Owner ChangeN/A
Market Cap7.52B
Revenue(TTM)3.05B
Net Income(TTM)346.30M
Analysts71.85
Price Target7.1 (16.2%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.67% |
Yearly Dividend0.04
Dividend Growth(5Y)-0.23%
DP22.52%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.53%
PT rev (3m)1.27%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-0.56%
EPS NY rev (3m)-0.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.36%
Revenue NY rev (3m)-1.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.07 | ||
| Fwd PE | 18.85 | ||
| P/S | 2.47 | ||
| P/FCF | 19.37 | ||
| P/OCF | 10.94 | ||
| P/B | 1.95 | ||
| P/tB | 18.96 | ||
| EV/EBITDA | 12.46 |
EPS(TTM)0.29
EY4.75%
EPS(NY)0.32
Fwd EY5.3%
FCF(TTM)0.32
FCFY5.16%
OCF(TTM)0.56
OCFY9.14%
SpS2.48
BVpS3.14
TBVpS0.32
PEG (NY)2.93
PEG (5Y)1.75
Graham Number4.52
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.27% | ||
| ROE | 8.97% | ||
| ROCE | 8.89% | ||
| ROIC | 6.57% | ||
| ROICexc | 7.34% | ||
| ROICexgc | 17.16% | ||
| OM | 19.74% | ||
| PM (TTM) | 11.35% | ||
| GM | 60.31% | ||
| FCFM | 12.73% |
ROA(3y)3.87%
ROA(5y)4.55%
ROE(3y)8.5%
ROE(5y)9.99%
ROIC(3y)6.98%
ROIC(5y)7.33%
ROICexc(3y)7.81%
ROICexc(5y)8.35%
ROICexgc(3y)19.64%
ROICexgc(5y)24.18%
ROCE(3y)9.45%
ROCE(5y)9.92%
ROICexgc growth 3Y-14.23%
ROICexgc growth 5Y-7.25%
ROICexc growth 3Y-6.36%
ROICexc growth 5Y1.27%
OM growth 3Y-1.78%
OM growth 5Y2.87%
PM growth 3Y-2.76%
PM growth 5Y1.37%
GM growth 3Y0.8%
GM growth 5Y0.82%
F-Score8
Asset Turnover0.38
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.59 | ||
| Debt/FCF | 6.6 | ||
| Debt/EBITDA | 3.02 | ||
| Cap/Depr | 201.82% | ||
| Cap/Sales | 9.81% | ||
| Interest Coverage | 6.43 | ||
| Cash Conversion | 91.62% | ||
| Profit Quality | 112.13% | ||
| Current Ratio | 2.22 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | 2.63 |
F-Score8
WACC6.57%
ROIC/WACC1
Cap/Depr(3y)282.75%
Cap/Depr(5y)284.75%
Cap/Sales(3y)11.87%
Cap/Sales(5y)11.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.22%
EPS 3Y-0.59%
EPS 5Y12.04%
EPS Q2Q%1418.89%
EPS Next Y7.18%
EPS Next 2Y9.68%
EPS Next 3Y13.95%
EPS Next 5Y18.72%
Revenue 1Y (TTM)-0.6%
Revenue growth 3Y4.19%
Revenue growth 5Y11.48%
Sales Q2Q%-2.8%
Revenue Next Year1.23%
Revenue Next 2Y3.1%
Revenue Next 3Y4.86%
Revenue Next 5Y3.29%
EBIT growth 1Y1.65%
EBIT growth 3Y2.34%
EBIT growth 5Y14.68%
EBIT Next Year26.5%
EBIT Next 3Y15.07%
EBIT Next 5Y19.58%
FCF growth 1Y84.55%
FCF growth 3Y149.17%
FCF growth 5Y15.69%
OCF growth 1Y2.55%
OCF growth 3Y21.81%
OCF growth 5Y20.37%
DAVIDE CAMPARI-MILANO NV / CPR.MI Fundamental Analysis FAQ
Can you provide the ChartMill fundamental rating for DAVIDE CAMPARI-MILANO NV?
ChartMill assigns a fundamental rating of 5 / 10 to CPR.MI.
What is the valuation status for CPR stock?
ChartMill assigns a valuation rating of 2 / 10 to DAVIDE CAMPARI-MILANO NV (CPR.MI). This can be considered as Overvalued.
What is the profitability of CPR stock?
DAVIDE CAMPARI-MILANO NV (CPR.MI) has a profitability rating of 7 / 10.
Can you provide the financial health for CPR stock?
The financial health rating of DAVIDE CAMPARI-MILANO NV (CPR.MI) is 5 / 10.
Can you provide the expected EPS growth for CPR stock?
The Earnings per Share (EPS) of DAVIDE CAMPARI-MILANO NV (CPR.MI) is expected to grow by 7.18% in the next year.